Prenetics Sells ACT Genomics Stake for $71.78 Million to Strengthen Bitcoin Financial Strategy
Nasdaq-listed company Prenetics has announced that it has reached a definitive agreement to transfer its ownership in ACT Genomics Holdings Company Limited to Delta Electronics, Inc. for approximately $71.78 million. The divestment of ACT Genomics has significantly strengthened Prenetics’ financial position, with cash reserves expected to reach around $86 million and total cash and short-term assets projected at $117 million. The company maintains a debt-free balance sheet, enabling it to explore other financial management options, including the adoption of digital assets and Bitcoin treasury strategies. (Globenewswire)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Circle mintes 250 million new USDC to USDC Treasury

Michael Saylor releases Bitcoin Tracker information again, possibly hinting at increased BTC holdings


